Royal DSM has acquired AVA, a Boston-based personalised nutrition platform that provides nutrition and coaching recommendations across a wide range of health and wellness segments. Financial details will not be disclosed at this time.
DSM has made Personalised Nutrition a key pillar in its nutrition strategy; this latest move unites previously announced partnerships and investments across the necessary key capabilities including personalised nutrition delivery platforms such as Panaceutics, Mixfit and Tespo.
Consumers are increasingly looking for science-based and data-driven nutritional solutions tailored to their specific health goals. AVA is a state-of-the-art digital health platform that leverages artificial intelligence to analyse behaviour, wellness and consumption patterns and provide end users with adaptive nutrition recommendations and live coaching. The platform is currently available in the US and Europe and can be fully customised to a wide variety of use cases.
We are delighted to welcome AVA into our family to build the end-to-end capabilities in our Personalised Nutrition offering
James Bauly, Head of Personalized Nutrition at DSM Nutritional Products, said: "We are delighted to welcome AVA into our family to build the end-to-end capabilities in our Personalised Nutrition offering. AVA's advanced technology provides sophisticated data analysis, recommendations and coaching for a broad range of target audiences."
Bauly explained that through combining AVA's operations with DSM's nutrition science, products and solutions, it aims to be the partner of choice for dietary supplement as well as food and beverage brand owners that wish to offer personalised and healthy nutrition and gain unique consumer insights.
Ian Brady, CEO of AVA said: "We are thrilled to be joining DSM that has long been a leader in the journey to personalised nutrition. Our mission has been to provide outcome-based solutions to a broader range of nutrition and wellness related consumer needs. Leveraging DSM's leading position in nutritional ingredients, unparalleled market reach and its scientific network allow us to accelerate these plans and expand our platform to a global audience."
